Cargando…

Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of β-Thalassemia and Sickle-Cell Anemia

The objective of this review is to present examples of lead compounds identified from biological material (fungi, plant extracts and agro-industry material) and of possible interest in the field of a pharmacological approach to the therapy of β-thalassemia using molecules able to stimulate productio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bianchi, Nicoletta, Zuccato, Cristina, Lampronti, Ilaria, Borgatti, Monica, Gambari, Roberto
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2009
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686630/ https://www.ncbi.nlm.nih.gov/pubmed/18955291 http://dx.doi.org/10.1093/ecam/nem139

Ejemplares similares

A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established Drugs
por: Prosdocimi, Marco, et al.
Publicado: (2022)

A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction
por: Zuccato, Cristina, et al.
Publicado: (2012)

Treatment of Erythroid Precursor Cells from β-Thalassemia Patients with Cinchona Alkaloids: Induction of Fetal Hemoglobin Production
por: Zuccato, Cristina, et al.
Publicado: (2021)

An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production
por: Breveglieri, Giulia, et al.
Publicado: (2017)

The rs368698783 (G>A) Polymorphism Affecting LYAR Binding to the Aγ-Globin Gene Is Associated with High Fetal Hemoglobin (HbF) in β-Thalassemia Erythroid Precursor Cells Treated with HbF Inducers
por: Zuccato, Cristina, et al.
Publicado: (2023)

A validated cellular biobank for β-thalassemia
por: Cosenza, Lucia Carmela, et al.
Publicado: (2016)

Co-Treatment of Erythroid Cells from β-Thalassemia Patients with CRISPR-Cas9-Based β(0)39-Globin Gene Editing and Induction of Fetal Hemoglobin
por: Cosenza, Lucia Carmela, et al.
Publicado: (2022)

Recent trends in the gene therapy of β-thalassemia
por: Finotti, Alessia, et al.
Publicado: (2015)

Natural Remedies for the Treatment of Beta-Thalassemia and Sickle Cell Anemia—Current Status and Perspectives in Fetal Hemoglobin Reactivation
por: Ng, Noel Yat Hey, et al.
Publicado: (2014)

Therapeutic Hemoglobin Levels after Gene Transfer in β-Thalassemia Mice and in Hematopoietic Cells of β-Thalassemia and Sickle Cells Disease Patients
por: Breda, Laura, et al.
Publicado: (2012)

Generation and Characterization of a Transgenic Mouse Carrying a Functional Human β-Globin Gene with the IVSI-6 Thalassemia Mutation
por: Breveglieri, Giulia, et al.
Publicado: (2015)

Inhibitory Effects of Bangladeshi Medicinal Plant Extracts on Interactions between Transcription Factors and Target DNA Sequences
por: Lampronti, Ilaria, et al.
Publicado: (2008)

UPF1 silenced cellular model systems for screening of read-through agents active on β(0)39 thalassemia point mutation
por: Salvatori, Francesca, et al.
Publicado: (2018)

Increase of microRNA-210, Decrease of Raptor Gene Expression and Alteration of Mammalian Target of Rapamycin Regulated Proteins following Mithramycin Treatment of Human Erythroid Cells
por: Bianchi, Nicoletta, et al.
Publicado: (2015)

Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells
por: MONTAGNER, GIULIA, et al.
Publicado: (2015)

Discovery of Novel Fetal Hemoglobin Inducers through Small Chemical Library Screening
por: Breveglieri, Giulia, et al.
Publicado: (2020)

Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2022)

5613398 A DRUG REPOSITIONING PROJECT FOR Β-THALASSEMIA: SIROLIMUS AND CINCHONA ALKALOIDS
por: Michele Lipucci Di Paola, M.L.P., et al.
Publicado: (2023)

Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin)
por: Zuccato, Cristina, et al.
Publicado: (2022)

Bergamot (Citrus bergamia Risso) fruit extracts and identified components alter expression of interleukin 8 gene in cystic fibrosis bronchial epithelial cell lines
por: Borgatti, Monica, et al.
Publicado: (2011)

Fetal hemoglobin and hemolysis markers in sickle cell anemia()
por: Colella, Marina Pereira, et al.
Publicado: (2015)

5613417 CO-TREATMENT OF ERYTHROID CELLS ISOLATED FROM Β039-THALASSEMIA PATIENTS WITH CRISPR-CAS9 GENE EDITING AND FETAL HEMOGLOBIN INDUCTION
por: Lipucci di Paola, M.L.P., et al.
Publicado: (2023)

Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin
por: Finotti, Alessia, et al.
Publicado: (2015)

MicroRNA Expression in β-Thalassemia and Sickle Cell Disease: A Role in The Induction of Fetal Hemoglobin
por: Saki, Najmaldin, et al.
Publicado: (2016)

Modulation of the Expression of the Proinflammatory IL-8 Gene in Cystic Fibrosis Cells by Extracts Deriving from Olive Mill Waste Water
por: Lampronti, Ilaria, et al.
Publicado: (2013)

Detection of the sickle hemoglobin allele using a surface plasmon resonance based biosensor
por: Breveglieri, Giulia, et al.
Publicado: (2019)

5613423 TREATMENT OF ERYTHROID PRECURSOR CELLS FROM β-THALASSEMIC PATIENTS WITH ISOXAZOLE DERIVATIVES: POTENT INDUCTION OF FETAL HEMOGLOBIN
por: Cristina Zuccato, C.Z., et al.
Publicado: (2023)

BCL11A mRNA Targeting by miR-210: A Possible Network Regulating γ-Globin Gene Expression
por: Gasparello, Jessica, et al.
Publicado: (2017)

Fetal hemoglobin reactivation and cell engineering in the treatment of sickle cell anemia
por: Eridani, Sandro, et al.
Publicado: (2011)

Combined approaches for increasing fetal hemoglobin (HbF) and de novo production of adult hemoglobin (HbA) in erythroid cells from β-thalassemia patients: treatment with HbF inducers and CRISPR-Cas9 based genome editing
por: Finotti, Alessia, et al.
Publicado: (2023)

MicroRNAs and Long Non-coding RNAs in Genetic Diseases
por: Finotti, Alessia, et al.
Publicado: (2019)

Effects of Sirolimus treatment on patients with β‐Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4 (+) and CD8 (+) T cells
por: Zurlo, Matteo, et al.
Publicado: (2023)

Genome Wide Association Study of Fetal Hemoglobin in Sickle Cell Anemia in Tanzania
por: Mtatiro, Siana Nkya, et al.
Publicado: (2014)

Sex-specific transcriptional profiles identified in β-thalassemia patients
por: Nanou, Aikaterini, et al.
Publicado: (2021)

Induction of Fetal Hemoglobin by Introducing Natural Hereditary Persistence of Fetal Hemoglobin Mutations in the γ-Globin Gene Promoters for Genome Editing Therapies for β-Thalassemia
por: Lu, Dian, et al.
Publicado: (2022)

Effects of Sirolimus Treatment on Fetal Hemoglobin Production and Response to SARS-CoV-2 Vaccination: A Case Report Study
por: Gamberini, Maria Rita, et al.
Publicado: (2023)

Role of Cystic Fibrosis Bronchial Epithelium in Neutrophil Chemotaxis
por: Cabrini, Giulio, et al.
Publicado: (2020)

Gum Arabic as fetal hemoglobin inducing agent in sickle cell anemia; in vivo study
por: Kaddam, Lamis, et al.
Publicado: (2015)

Postnatal and non-invasive prenatal detection of β-thalassemia mutations based on Taqman genotyping assays
por: Breveglieri, Giulia, et al.
Publicado: (2017)

Genetic Correction of Sickle Cell Anemia and β-Thalassemia: Progress and New Perspective
por: Perumbeti, Ajay, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_e2d0htji00rvka3q49ljmlgc29